Navigation Links
R3 International Offering New Program for Stem Cell Therapy for Alzheimers Dementia in Mexico
Date:7/7/2020

R3 International is now offering stem cell therapy for Alzheimers dementia in Mexico with a new program featuring up to 200 million stem cells. Depending on the patient's condition, treatment may be offered IV, intrathecal or with a combination.

A third of seniors in the US will die having some form of Alzheimers dementia, and the incidence continues to increase as individuals live longer. There is no cure, and conventional treatments often do not help dramatically.

Enter stem cell therapy for Alzheimers in Mexico at R3 International. Several early studies have showed significant benefit for Alzheimers disease with stem cell treatment (Curr Opin Psychiatry, 2019).

Stem cells have the potential of altering regeneration of neurons and synapses. Anecdotally, R3 Stem Cell International has seen amazing response with patients suffering from Alzheimers dementia with regards to memory, conversational ability and ability to perform activities of daily living.

There are several treatment options in Tijuana with R3 International. Patients may receive a one time treatment with 30 million stem cells for only $2975, or receive 50 million stem cells for $1000 more.

The newest program at R3 International involves either a 5 day visit for several treatments, or four visits over a year. Treatment involves up to 200 million stem cells for these treatment options, which is an excellent amount for the Alzheimers treatment. These options start at only $8975.

Along with effective stem cell treatment options for Alzheimers, R3 International also offers effective stem cell therapy for stroke, neuropathy, ALS, MS, diabetes, liver/kidney failure, COPD, arthritis, Lupus, Lyme, psoriasis, RA and more.

The process starts with a free phone consultation with one of R3's licensed, experience stem cell doctors. Once treatment is then scheduled, the patient concierge representative will assist with travel logistics. Transportation is offered between San Diego and the clinic, which is only 20 minutes from the SA airport.

To discuss stem cell treatment in Mexico options with R3, call (888) 988-0515.

Read the full story at https://www.prweb.com/releases/r3_international_offering_new_program_for_stem_cell_therapy_for_alzheimers_dementia_in_mexico/prweb17223643.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology technology :

1. Forecast International: Microturbines Growing in Power and Value
2. Shoreline Biome Announces International Distribution Partnerships
3. Thought Technology Ltd Continues to Grow International Distribution Network with UK Partner
4. EyeCRO Receives Full Accreditation from AAALAC International for its Research Facilities
5. MabPlex International Ltd. Secures $59.1 Million Series A Financing Round
6. MabPlex International, Ltd. Opens New Phase III and Commercial Manufacturing Facility
7. Heart failure caregivers face critical gaps in resources and support, new international study shows
8. New Ag International will host the 3rd Biostimulants World Congress in Miami, 27-30 November 2017
9. CNA Finance Initiates Research Coverage On Youngevity International
10. Distinguished Cardiologists and Scientists Honored with 2017 International Academy of Cardiology Awards at the 22nd World Congress on Heart Disease, Vancouver, BC, Canada
11. National Aeromodeling Championships Underway at International Aeromodeling Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2020)... ... June 23, 2020 , ... Kerafast Inc. ... materials, today announced the availability of the Delta-G-VSV Pseudotyping System for coronavirus research ... enables studies of SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety ...
(Date:6/23/2020)... ... June 22, 2020 , ... Regen ... special offer. This includes buy three, get the fourth unit free with no ... Amniotic derived exosomes, known as exosomes, have been a game changer for regenerative ...
(Date:6/23/2020)... Ore. (PRWEB) , ... June 23, 2020 , ... ... of innovative CNS therapies, today announced that it has filed an Investigational New ... a Phase 2b clinical trial of its lead drug candidate NBTX-001 in patients ...
(Date:6/11/2020)... ... June 08, 2020 , ... Greffex, a leading genetic ... of proprietary clean viral vectors, recently announced a key manufacturing agreement with FUJIFILM ... is the world’s most successful gene therapy delivery vehicle (vector) with broad applications ...
Breaking Biology Technology:
(Date:7/2/2020)... FREDERICK, Md. (PRWEB) , ... ... ... company, Molecular Biology Systems, B.V. (MBS) has announced a publication detailing the ... a one-step reverse transcription polymerase chain reaction (RT-PCR) in 16 minutes. The ...
(Date:6/28/2020)... (PRWEB) , ... June 25, ... ... of enterprise software solutions for biopharmaceutical R&D, today announced that it has ... developing innovative, full-length multispecific antibodies (Multiclonics®), to support their translational and clinical ...
(Date:6/23/2020)... FREDERICK, Md. (PRWEB) , ... ... ... a leading provider of gene-to-protein and monoclonal antibody development services, today announced ... of protein-based products and services to the pharmaceutical, diagnostics, and research industries. ...
Breaking Biology News(10 mins):